This measure assesses the appropriate use of noninvasive ischemic imaging in patients with chronic coronary disease in accordance with the 2023 ACC/AHA guidelines on the management of chronic coronary disease. It evaluates the percentage of patients who received imaging without a clinical change or pre-operative indication, signaling potential overuse of cardiac imaging.